Celltrion officially announced that press articles regarding stake sale of Celltrion
On July 31st, Celltrion officially announced that press articles regarding stake sale of Celltrion to AstraZeneca was falsely reported by some press.
Celltrion’s largest shareholder is currently under discussion with its financial advisor, J.P. Morgan, but no definite structure or decision regarding the stake sale has been determined at current stage.
Celltrion is doing its best to assist the largest shareholder in the announced stake sale to fulfill the best interest of Celltrion’s business and Korea’s pharmaceutical industry.
Celltrion Public Relations
Phone: +82-32-850-5153 / e-mail:email@example.com